← FDA Drug Approvals (Drugs@FDA)

LYNKUET

NDA · New Drug Application · Sponsor: BAYER HLTHCARE · Approved 2025-10-24

Drug application

FDA Application #

NDA219469

Application type

New Drug Application

Brand name

LYNKUET

Generic name

ELINZANETANT

Active ingredients

ELINZANETANT

Dosage form

CAPSULE

Route

ORAL

Marketing status

Prescription

Sponsor

BAYER HLTHCARE

Manufacturer

Bayer HealthCare Pharmaceuticals Inc.

First approval

2025-10-24

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown